A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention

NCT01327183 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

532

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarction

Interventions

PROCEDURE: Percutaneous Coronary Intervention (PCI)
DRUG: RO4905417
DRUG: RO4905417
DRUG: placebo

Sponsor

Hoffmann-La Roche